Markers of endogenous desaturase activity and risk of coronary heart disease in the CAREMA cohort study.
<h4>Background</h4>Intakes of n-3 polyunsaturated fatty acids (PUFAs), especially EPA (C20:5n-3) and DHA (C22:6n-3), are known to prevent fatal coronary heart disease (CHD). The effects of n-6 PUFAs including arachidonic acid (C20:4n-6), however, remain unclear. δ-5 and δ-6 desaturases a...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/0b15f566918a445fab69bc7311bd0dac |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:0b15f566918a445fab69bc7311bd0dac |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:0b15f566918a445fab69bc7311bd0dac2021-11-18T07:11:23ZMarkers of endogenous desaturase activity and risk of coronary heart disease in the CAREMA cohort study.1932-620310.1371/journal.pone.0041681https://doaj.org/article/0b15f566918a445fab69bc7311bd0dac2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22911844/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Intakes of n-3 polyunsaturated fatty acids (PUFAs), especially EPA (C20:5n-3) and DHA (C22:6n-3), are known to prevent fatal coronary heart disease (CHD). The effects of n-6 PUFAs including arachidonic acid (C20:4n-6), however, remain unclear. δ-5 and δ-6 desaturases are rate-limiting enzymes for synthesizing long-chain n-3 and n-6 PUFAs. C20:4n-6 to C20:3n-6 and C18:3n-6 to C18:2n-6 ratios are markers of endogenous δ-5 and δ-6 desaturase activities, but have never been studied in relation to incident CHD. Therefore, the aim of this study was to investigate the relation between these ratios as well as genotypes of FADS1 rs174547 and CHD incidence.<h4>Methods</h4>We applied a case-cohort design within the CAREMA cohort, a large prospective study among the general Dutch population followed up for a median of 12.1 years. Fatty acid profile in plasma cholesteryl esters and FADS1 genotype at baseline were measured in a random subcohort (n = 1323) and incident CHD cases (n = 537). Main outcome measures were hazard ratios (HRs) of incident CHD adjusted for major CHD risk factors.<h4>Results</h4>The AA genotype of rs174547 was associated with increased plasma levels of C204n-6, C20:5n-3 and C22:6n-3 and increased δ-5 and δ-6 desaturase activities, but not with CHD risk. In multivariable adjusted models, high baseline δ-5 desaturase activity was associated with reduced CHD risk (P for trend = 0.02), especially among those carrying the high desaturase activity genotype (AA): HR (95% CI) = 0.35 (0.15-0.81) for comparing the extreme quintiles. High plasma DHA levels were also associated with reduced CHD risk.<h4>Conclusion</h4>In this prospective cohort study, we observed a reduced CHD risk with an increased C20:4n-6 to C20:3n-6 ratio, suggesting that δ-5 desaturase activity plays a role in CHD etiology. This should be investigated further in other independent studies.Yingchang LuAnika VaarhorstAudrey H H MerryMartijn E T DolléRobert HovenierSandra ImholzLeo J SchoutenBastiaan T HeijmansMichael MüllerP Eline SlagboomPiet A van den BrandtAnton P M GorgelsJolanda M A BoerEdith J M FeskensPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 7, p e41681 (2012) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Yingchang Lu Anika Vaarhorst Audrey H H Merry Martijn E T Dollé Robert Hovenier Sandra Imholz Leo J Schouten Bastiaan T Heijmans Michael Müller P Eline Slagboom Piet A van den Brandt Anton P M Gorgels Jolanda M A Boer Edith J M Feskens Markers of endogenous desaturase activity and risk of coronary heart disease in the CAREMA cohort study. |
| description |
<h4>Background</h4>Intakes of n-3 polyunsaturated fatty acids (PUFAs), especially EPA (C20:5n-3) and DHA (C22:6n-3), are known to prevent fatal coronary heart disease (CHD). The effects of n-6 PUFAs including arachidonic acid (C20:4n-6), however, remain unclear. δ-5 and δ-6 desaturases are rate-limiting enzymes for synthesizing long-chain n-3 and n-6 PUFAs. C20:4n-6 to C20:3n-6 and C18:3n-6 to C18:2n-6 ratios are markers of endogenous δ-5 and δ-6 desaturase activities, but have never been studied in relation to incident CHD. Therefore, the aim of this study was to investigate the relation between these ratios as well as genotypes of FADS1 rs174547 and CHD incidence.<h4>Methods</h4>We applied a case-cohort design within the CAREMA cohort, a large prospective study among the general Dutch population followed up for a median of 12.1 years. Fatty acid profile in plasma cholesteryl esters and FADS1 genotype at baseline were measured in a random subcohort (n = 1323) and incident CHD cases (n = 537). Main outcome measures were hazard ratios (HRs) of incident CHD adjusted for major CHD risk factors.<h4>Results</h4>The AA genotype of rs174547 was associated with increased plasma levels of C204n-6, C20:5n-3 and C22:6n-3 and increased δ-5 and δ-6 desaturase activities, but not with CHD risk. In multivariable adjusted models, high baseline δ-5 desaturase activity was associated with reduced CHD risk (P for trend = 0.02), especially among those carrying the high desaturase activity genotype (AA): HR (95% CI) = 0.35 (0.15-0.81) for comparing the extreme quintiles. High plasma DHA levels were also associated with reduced CHD risk.<h4>Conclusion</h4>In this prospective cohort study, we observed a reduced CHD risk with an increased C20:4n-6 to C20:3n-6 ratio, suggesting that δ-5 desaturase activity plays a role in CHD etiology. This should be investigated further in other independent studies. |
| format |
article |
| author |
Yingchang Lu Anika Vaarhorst Audrey H H Merry Martijn E T Dollé Robert Hovenier Sandra Imholz Leo J Schouten Bastiaan T Heijmans Michael Müller P Eline Slagboom Piet A van den Brandt Anton P M Gorgels Jolanda M A Boer Edith J M Feskens |
| author_facet |
Yingchang Lu Anika Vaarhorst Audrey H H Merry Martijn E T Dollé Robert Hovenier Sandra Imholz Leo J Schouten Bastiaan T Heijmans Michael Müller P Eline Slagboom Piet A van den Brandt Anton P M Gorgels Jolanda M A Boer Edith J M Feskens |
| author_sort |
Yingchang Lu |
| title |
Markers of endogenous desaturase activity and risk of coronary heart disease in the CAREMA cohort study. |
| title_short |
Markers of endogenous desaturase activity and risk of coronary heart disease in the CAREMA cohort study. |
| title_full |
Markers of endogenous desaturase activity and risk of coronary heart disease in the CAREMA cohort study. |
| title_fullStr |
Markers of endogenous desaturase activity and risk of coronary heart disease in the CAREMA cohort study. |
| title_full_unstemmed |
Markers of endogenous desaturase activity and risk of coronary heart disease in the CAREMA cohort study. |
| title_sort |
markers of endogenous desaturase activity and risk of coronary heart disease in the carema cohort study. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2012 |
| url |
https://doaj.org/article/0b15f566918a445fab69bc7311bd0dac |
| work_keys_str_mv |
AT yingchanglu markersofendogenousdesaturaseactivityandriskofcoronaryheartdiseaseinthecaremacohortstudy AT anikavaarhorst markersofendogenousdesaturaseactivityandriskofcoronaryheartdiseaseinthecaremacohortstudy AT audreyhhmerry markersofendogenousdesaturaseactivityandriskofcoronaryheartdiseaseinthecaremacohortstudy AT martijnetdolle markersofendogenousdesaturaseactivityandriskofcoronaryheartdiseaseinthecaremacohortstudy AT roberthovenier markersofendogenousdesaturaseactivityandriskofcoronaryheartdiseaseinthecaremacohortstudy AT sandraimholz markersofendogenousdesaturaseactivityandriskofcoronaryheartdiseaseinthecaremacohortstudy AT leojschouten markersofendogenousdesaturaseactivityandriskofcoronaryheartdiseaseinthecaremacohortstudy AT bastiaantheijmans markersofendogenousdesaturaseactivityandriskofcoronaryheartdiseaseinthecaremacohortstudy AT michaelmuller markersofendogenousdesaturaseactivityandriskofcoronaryheartdiseaseinthecaremacohortstudy AT pelineslagboom markersofendogenousdesaturaseactivityandriskofcoronaryheartdiseaseinthecaremacohortstudy AT pietavandenbrandt markersofendogenousdesaturaseactivityandriskofcoronaryheartdiseaseinthecaremacohortstudy AT antonpmgorgels markersofendogenousdesaturaseactivityandriskofcoronaryheartdiseaseinthecaremacohortstudy AT jolandamaboer markersofendogenousdesaturaseactivityandriskofcoronaryheartdiseaseinthecaremacohortstudy AT edithjmfeskens markersofendogenousdesaturaseactivityandriskofcoronaryheartdiseaseinthecaremacohortstudy |
| _version_ |
1718423770987757568 |